Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
A report published last week by the Business Group on Health estimates large employers are preparing for a 7.8% spike in healthcare costs next year, largely due to increased spending on pharmaceuticals like GLP-1s
joined the Board and the Special Committee as a third disinterested manager on December 21, 2025
TRIUMPH-1 (NCT05929066): A Study of Retatrutide in Adults With Obesity or Overweight (Phase 3)
There are no reported differences in side effects between the red variant and other semaglutide formulations
US$ 27.06
US$ 21.71
.webp)
US$ 28.87
US$ 25.36
US$ 25.07
US$ 24.95
